Where Zimmer Biomet Holdings Stands With Analysts
Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:
Loop Capital Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $140
Loop Capital analyst Jason Wittes maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $165 to $140.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.
What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:
10 Biggest Price Target Changes For Tuesday
Keybanc raised Take-Two Interactive Software, Inc. (NASDAQ: TTWO) price target from $185 to $190. Take-Two Interactive shares fell 2.8% to $170.21 in pre-market trading.
Deutsche Bank Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $121
Deutsche Bank analyst Pito Chickering maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price target from $140 to $121.
Needham Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $143
Needham analyst Mike Matson maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $155 to $143.
SVB Leerink Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $135
SVB Leerink analyst Danielle Antalffy maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $150 to $135.
Canaccord Genuity Downgrades Zimmer Biomet Holdings to Hold, Lowers Price Target to $125
Canaccord Genuity analyst Kyle Rose downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Buy to Hold and lowers the price target from $165 to $125.